Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Adipose-derived MSCs for Early Knee Osteoarthritis
NCT03956719Unknown
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Mar 2019
- Primary completion
- Sep 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of autologous adipose-derived mesenchymal stromal cells in knee osteoarthritis (OA), sponsored by Qilu Hospital of Shandong University. Primary endpoints: Hospital for Special Surgery Knee Score at 6 months, Visual Analogue Scale at 6 months and 3 more. Status: unknown.
02
Drugs
autologous adipose-derived mesenchymal stromal cells
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03956719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03956719.